The ubiquitin–proteasome system (UPS) and autophagy are two distinct and interacting proteolytic systems. They play critical roles in cell survival under normal conditions and during stress. An increasing body of evidence indicates that ubiquitinated cargoes are important markers of degradation. p62, a classical receptor of autophagy, is a multifunctional protein located throughout the cell and involved in many signal transduction pathways, including the Keap1–Nrf2 pathway. It is involved in the proteasomal degradation of ubiquitinated proteins. When the cellular p62 level is manipulated, the quantity and location pattern of ubiquitinated proteins change with a considerable impact on cell survival. Altered p62 levels can even lead to some diseases. The proteotoxic stress imposed by proteasome inhibition can activate autophagy through p62 phosphorylation. A deficiency in autophagy may compromise the ubiquitin–proteasome system, since overabundant p62 delays delivery of the proteasomal substrate to the proteasome despite proteasomal catalytic activity being unchanged. In addition, p62 and the proteasome can modulate the activity of HDAC6 deacetylase, thus influencing the autophagic degradation.
Metal-organic framework (MOF) NH2 -Uio-66(Zr) exhibits photocatalytic activity for CO2 reduction in the presence of triethanolamine as sacrificial agent under visible-light irradiation. Photoinduced electron transfer from the excited 2-aminoterephthalate (ATA) to Zr oxo clusters in NH2 -Uio-66(Zr) was for the first time revealed by photoluminescence studies. Generation of Zr(III) and its involvement in photocatalytic CO2 reduction was confirmed by ESR analysis. Moreover, NH2 -Uio-66(Zr) with mixed ATA and 2,5-diaminoterephthalate (DTA) ligands was prepared and shown to exhibit higher performance for photocatalytic CO2 reduction due to its enhanced light adsorption and increased adsorption of CO2 . This study provides a better understanding of photocatalytic CO2 reduction over MOF-based photocatalysts and also demonstrates the great potential of using MOFs as highly stable, molecularly tunable, and recyclable photocatalysts in CO2 reduction.
This study demonstrates that large-size graphene oxide (GO) sheets can impart a tremendous positive impact on self-alignment, electrical conductivity, and mechanical properties of graphene papers. There is a remarkable, more than 3-fold improvement in electrical conductivity of the papers made from ultralarge GO sheets (with an average area of 272.2 μm(2)) compared to that of the small GO counterpart (with an average area of 1.1 μm(2)). The corresponding improvements in Young's modulus and tensile strength are equally notable, namely 320% and 280%, respectively. These improvements of bulk properties due to the large GO sheets are correlated to multiscale elemental and structural characteristics of GO sheets, such as the content of carboxyl groups on the GO edge, C/O ratio and Raman D/G-band intensity ratio of GO on the molecular-scale, and the degree of dispersion and stacking behavior of GO sheets on the microscale. The graphene papers made from larger GO sheets exhibit a closer-stacked structure and better alignment as confirmed by the fast Fourier transform analysis, to the benefits of their electrical conductivity and mechanical properties. The molecular dynamics simulation further elucidates that the enhanced intersheet interactions between large GO sheets play a key role in improving the Young's modulus of GO papers. The implication is that the said properties can be further improved by enhancing the intersheet stress transfer and electrical conduction especially through the thickness direction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.